RxSight Q4 Prelim Revenue Surges; Expects 2024 Revenue To Improve Above Estimates

RxSight, Inc. (RXST), ophthalmic medical devices provider, reported a surge in preliminary revenue for the fourth-quarter. For the fourth-quarter, RxSight expects to register revenue of around $28.

Related Keywords

,Thomson Reuters ,Rxsight Inc ,Delivery Devices ,Adjustable Lenses ,Rxsight ,Nc ,